RENOVOGEM
Live / Applied — Third extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 21 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98142360
- Mark type
- Stylized text
- Filed
- 21 Aug 2023
- Published for opposition
- 28 May 2024
- Attorney of record
- Christopher Erickson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer
Owner
- RenovoRx, Inc., Los Altos, CA, US
- RenovoRx, Inc., Los Altos, CA, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 3 GRANTED
- 18 Nov 2025 — SOU EXTENSION 3 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2025 — SOU EXTENSION 2 GRANTED
- 22 Jul 2025 — SOU EXTENSION 2 FILED
- 22 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2024 — SOU EXTENSION 1 GRANTED
- 30 Dec 2024 — SOU EXTENSION 1 FILED
- 30 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION